17901552|t|Function of COX-2 and prostaglandins in neurological disease.
17901552|a|Induction of COX-2 expression and enzymatic activity promotes neuronal injury in a number of models of neurological disease. Inhibition of COX-2 activity, either genetically or pharmacologically, has been shown to be neuroprotective in rodent models of stroke, Parkinson's disease, and amyotrophic lateral sclerosis. Inhibition of COX activity with nonsteroidal anti-inflammatory drugs (NSAIDs) reduces inflammation and amyloid accumulation in murine transgenic models of Familial Alzheimer's disease, and the use of NSAIDs decreases the risk of developing Alzheimer's disease in healthy aging populations. COX-mediated neuronal injury is presumed be due to downstream effects of one or more prostaglandin products including PGE2, PGD2, PGF2alpha, PGI2 (prostacylin) and TXA2 (thromboxane) that effect cellular changes through activation of specific prostaglandin receptor subtypes and second messenger systems. In this proceeding, we review recent data demonstrating effects of prostaglandin signaling on neuronal viability that are paradoxically protective, when taken in the context that COX-2 induces neuronal injury in the setting of excitotoxicity. Conversely, in the context of an inflammatory stimulus, the EP2 receptor enhances neuronal injury. These findings argue for an additional level of complexity in the prostaglandin response in neurological disease.
17901552	12	17	COX-2	Gene	17709
17901552	22	36	prostaglandins	Chemical	MESH:D011453
17901552	40	60	neurological disease	Disease	MESH:D020271
17901552	75	80	COX-2	Gene	17709
17901552	124	139	neuronal injury	Disease	MESH:D009410
17901552	165	185	neurological disease	Disease	MESH:D020271
17901552	201	206	COX-2	Gene	17709
17901552	315	321	stroke	Disease	MESH:D020521
17901552	323	342	Parkinson's disease	Disease	MESH:D010300
17901552	348	377	amyotrophic lateral sclerosis	Disease	MESH:D000690
17901552	393	396	COX	Gene	12857
17901552	465	477	inflammation	Disease	MESH:D007249
17901552	482	502	amyloid accumulation	Disease	MESH:C000718787
17901552	506	512	murine	Species	10090
17901552	534	562	Familial Alzheimer's disease	Disease	MESH:D000544
17901552	619	638	Alzheimer's disease	Disease	MESH:D000544
17901552	669	672	COX	Gene	12857
17901552	682	697	neuronal injury	Disease	MESH:D009410
17901552	754	767	prostaglandin	Chemical	MESH:D011453
17901552	787	791	PGE2	Chemical	MESH:D015232
17901552	793	797	PGD2	Chemical	MESH:D015230
17901552	799	808	PGF2alpha	Chemical	MESH:D015237
17901552	810	814	PGI2	Chemical	MESH:D011464
17901552	816	827	prostacylin	Chemical	-
17901552	833	837	TXA2	Chemical	MESH:D013928
17901552	839	850	thromboxane	Chemical	MESH:D013931
17901552	1041	1054	prostaglandin	Chemical	MESH:D011453
17901552	1153	1158	COX-2	Gene	17709
17901552	1167	1182	neuronal injury	Disease	MESH:D009410
17901552	1201	1215	excitotoxicity	Disease	
17901552	1250	1262	inflammatory	Disease	MESH:D007249
17901552	1277	1289	EP2 receptor	Gene	19217
17901552	1299	1314	neuronal injury	Disease	MESH:D009410
17901552	1382	1395	prostaglandin	Chemical	MESH:D011453
17901552	1408	1428	neurological disease	Disease	MESH:D020271
17901552	Association	MESH:D013928	12857
17901552	Positive_Correlation	MESH:D011464	MESH:D009410
17901552	Positive_Correlation	MESH:D009410	17709
17901552	Association	MESH:D011453	MESH:D020271
17901552	Positive_Correlation	MESH:D013928	MESH:D009410
17901552	Association	MESH:C000718787	12857
17901552	Positive_Correlation	MESH:D015232	MESH:D009410
17901552	Association	MESH:D010300	17709
17901552	Positive_Correlation	MESH:D015237	MESH:D009410
17901552	Association	MESH:D000690	17709
17901552	Positive_Correlation	MESH:D015230	MESH:D009410
17901552	Association	MESH:D000544	12857
17901552	Association	MESH:D020271	17709
17901552	Positive_Correlation	MESH:D013931	MESH:D009410
17901552	Association	MESH:D009410	19217
17901552	Positive_Correlation	MESH:D011453	MESH:D009410

